Moderna COVID-19 vaccine linked to more delayed cutaneous reactions Dr. Shravani Dali9 March 2023 12:00 PM ISTModerna COVID-19 vaccine linked to more delayed cutaneous reactions suggests a new study published in The Journal of Allergy and Clinical...
USFDA approves intramuscular administration for Merck’s MMRV Family of Vaccines: M-M-RII, VARIVAX, ProQuad Ruchika Sharma7 March 2023 11:22 AM ISTProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12...
Revise Phase II/III CT protocol of Yellow Fever Vaccine Live: CDSCO Panel Tells Serum Institute of India Dr. Divya Colin4 March 2023 6:00 PM ISTNew Delhi: Reviewing the proposal presented by the vaccine maker Serum Institute of India to conduct Phase II/III clinical trial of Yellow Fever...
Health Ministry gets Porter Prize 2023 for COVID-19 management Kajal Rajput3 March 2023 1:00 PM ISTThe prize recognizes the strategy followed by the Government of India in managing COVID-19, the approach, and involvement of various stakeholders...
Pfizer, BioNTech submit application to USFDA for emergency use nod of Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma2 March 2023 4:15 PM ISTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use...
Respiratory Syncytial virus vaccine effective in older adults, finds NEJM study Jacinthlyn Sylvia27 Feb 2023 8:00 PM ISTA recent study published in The New England Journal of Medicine suggest that a single dose of the Respiratory syncytial virus prefusion F...
Pfizer RSV vaccine for elderly linked to Guillain-Barre risk, says USFDA MD Bureau27 Feb 2023 4:30 PM ISTPfizer stated that its shot is a "well-tolerated and safe vaccine, with a benefit-to-risk ratio that is favourable".
Wockhardt plans to roll out two vaccines within year from UK facility as part of a tie-up with SII Ruchika Sharma27 Feb 2023 2:30 PM ISTNew Delhi: Drug firm Wockhardt plans to roll out two vaccines within a year from its UK-based facility as part of a tie-up with Serum Institute...
Pfizer, BioNTech seek USFDA nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine for ages 12 years and older as primary series or booster Ruchika Sharma25 Feb 2023 12:30 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that they have submitted a supplemental Biologics License Application (sBLA) to the U.S....
Pfizer Respiratory Syncytial Virus Maternal Vaccine candidate gets USFDA priority review Ruchika Sharma24 Feb 2023 1:30 PM ISTRSV is a contagious virus and a common cause of respiratory illness.
Moderna-Merck gets USFDA Breakthrough Therapy Designation for personalized mRNA cancer vaccine in combination with KEYTRUDA to treat high risk melanoma Ruchika Sharma23 Feb 2023 2:45 PM ISTCambridge: Moderna, Inc. and Merck have announced that mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, in combination with...
Clinical trials for BioNTech cancer vaccines should start this year in Britain: Ugur Sahin Ruchika Sharma21 Feb 2023 1:30 PM IST"We believe that this should be possible for large amounts of patients before 2030," Sahin said.
